Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
24.28
+0.88 (3.76%)
Dec 20, 2024, 4:00 PM EST - Market closed
Septerna Revenue
Septerna had revenue of $176.00K in the quarter ending September 30, 2024, with 433.33% growth. This brings the company's revenue in the last twelve months to $981.00K. In the year 2023, Septerna had annual revenue of $151.00K.
Revenue (ttm)
$981.00K
Revenue Growth
n/a
P/S Ratio
56.57
Revenue / Employee
$14,426
Employees
68
Market Cap
1.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 151.00K | - | - |
Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSEPN News
- 3 days ago - Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 4 weeks ago - Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones - Benzinga
- 7 weeks ago - Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering - GlobeNewsWire
- 2 months ago - U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha
- 2 months ago - Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut - Reuters
- 2 months ago - Septerna Prices Upsized Initial Public Offering - GlobeNewsWire
- 2 months ago - Goldman-backed drug developer Septerna targets $743 mln valuation in upsized US IPO - Reuters